Back to all companies
Sign in
Back to all companies
Evolvere BioSciences logo

Evolvere BioSciences

Summer 2024Active

Making Next-Generation Antibiotics that Outpace Bacterial Evolution

Save
Evolvere BioSciences logo

Evolvere BioSciences

Summer 2024Active

Making Next-Generation Antibiotics that Outpace Bacterial Evolution

Save
Company details

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells.

☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈.

🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️.

We are a team of biochemists and evolutionary biologists who met at the University of Oxford.

Location
Oxford, England, United Kingdom
Founded
Unknown
Category
AI-powered Drug Discovery
YC Directory Pagewww.evolverebiosciences.com
Founders
  • AW
    Adam Winnifrith
    Founder
    LinkedIn
  • PJ
    Piotr Jedryszek
    Founder
    LinkedIn
  • WS
    Weronika Slesak
    Founder
    LinkedIn

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells.

☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈.

🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️.

We are a team of biochemists and evolutionary biologists who met at the University of Oxford.

Location
Oxford, England, United Kingdom
Founded
Unknown
Category
AI-powered Drug Discovery
YC Directory Pagewww.evolverebiosciences.com
Founders
  • AW
    Adam Winnifrith
    Founder
    LinkedIn
  • PJ
    Piotr Jedryszek
    Founder
    LinkedIn
  • WS
    Weronika Slesak
    Founder
    LinkedIn
Pro

Upgrade to Pro, then request the Evolvere BioSciences teardown.

This company does not have a completed analysis yet. Choose a Pro plan first, then use one of your 5 monthly research requests to have our agent investigate Evolvere BioSciences. The full teardown, rebuild plan, and technical specs unlock when it lands.

  • Use Pro to request the first Evolvere BioSciences teardown and keep the finished report in your account.
  • Read every completed teardown and rebuild plan already in the database.
  • Unlock implementation-ready technical specs and 5 fresh research requests each month.

Choose your Pro plan

$20/ month

Find one worth rebuilding, get the teardown, open the implementation-ready specs, and use fresh report requests when you want deeper research.

See Pro plans
Full teardown library
Specs for every company
5 fresh requests / month
CLI for agent imports
Startups.RIP — Dead startups, alive ideas
PricingContactPrivacyGot feedback? DM @oscrhong